Monogram Health is a leading renal disease care management company providing an innovative care model and data-driven solutions to transform care for patients living with chronic kidney and end-stage renal disease.
Monogram Health is dedicated to improving the well being, quality of life and health outcomes for our patients by partnering with the nation's leading kidney specialists to provide transformative kidney care.
Monogram Health was founded in 2019 by Mike Uchrin and Christopher A. Booker. The company is headquartered in Nashville, Tennessee.
Monogram uses next generation artificial intelligence algorithms to predict necessary and timely care to promote the delay of Kidney Disease progression, seamless transitions to dialysis and/or pre-emptive kidney transplant, as well as to optimize our patients’ health outcomes once on dialysis.
Monogram partners with health plans to collaborate with nephrologists and ensure high-quality patient care is delivered cost effectively. Monogram’s care management team of nurses, social workers, nephrologists, and geriatricians develop strong and lasting relationships with patients through in-person visits to their homes.
Monogram currently operates its renal disease benefit management programs and in-home nephrology clinic across 20 states in the U.S. and has built a national network of nephrologists that includes hundreds of leading kidney care specialists.
Monogram is backed by TPG Capital, Frist Cressey Ventures, Norwest Venture Partners, Humana Inc, and others. The company raised $160M in Series B round on June 08, 2021. This brings Monogram's total funding to $172M to date.